Multiple Myeloma Knowledge Hub

Comparing Three Monoclonal Antibodies With Combined Drugs in Multiple Myeloma

A meta-analysis, published in BMC Cancer, compared the safety and effectiveness of three monoclonal antibodies (MAbs) with different targets, when combined with proteasome inhibitors or immunomodulators and dexamethasone/prednisone, in treatment of patients with multiple...

Expert Interviews

Curated Journal reading List